IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2− breast cancer via CX3CR1+ macrophages
Giulia Petroni, Claudia Galassi, Kenneth Gouin, Hsiang‐Han Chen, Aitziber Buqué, Norma Bloy, Takahiro Yamazaki, Ai Sato, Manuel Beltrán‐Visiedo, Ginevra Campia, Carlos Jiménez‐Cortegana, Aagam Shah, Alexander Kirchmair, Chiara Massa, Claudia Wickenhauser, Carlos Eduardo de Andrea, Belén Navarro-Rubio, Irantzu Serrano-Mendioroz, Esther Navarro Manzano, Alexandra Satty, Brady Rippon, Francesca Finotello, Zlatko Trajanoski, Xi Kathy Zhou, Joseph M. Scandura, Elena García‐Martínez, Francisco Ayala, María E. Rodríguez-Ruiz, Barbara Seliger, Víctor Sánchez‐Margalet, Luis de la Cruz‐Merino, Reva Basho, Stephen L. Shiao, Heather L. McArthur, Silvia C. Formenti, Simon Knott, Lorenzo Galluzzi
Topics & Concepts
CX3CR1Cancer researchCancerBreast cancerCyclin-dependent kinase 6MedicineInternal medicineReceptorChemokineCell cycleCyclin-dependent kinase 2Chemokine receptorAdvanced Breast Cancer TherapiesCancer Immunotherapy and BiomarkersChronic Lymphocytic Leukemia Research